CDX2 and colorectal carcinoma: Importantly, these effects were observed exclusively in CDX2-low CRC models—cell lines, xenografts, and PDOs—but not in CDX2-high PDOs or healthy colon PDOs (Figure 4A-columns 5 and 6; Figure S6C, S6F, and S6I).